|
CN111093694A
|
|
Chlamydia nanoemulsion vaccine
|
|
US2020246449A1
|
|
Intravenous immunoglobulin compositions specific for respiratory syncytial virus and methods of making and using the same
|
|
US2017007690A1
|
|
Methods and compositions for the stabilization of anthrax recombinant protective antigen
|
|
US2019000761A1
|
|
Methods of treating acne using nanoemulsion compositions
|
|
EP3319930A1
|
|
Methods and compositions for the stabilizaton of proteins
|
|
WO2017007835A1
|
|
Methods and compositions for nanoemulsion vaccine formulations
|
|
CN104093421A
|
|
Nanoemulsion respiratory syncytial virus (RSV) subunit vaccine
|
|
CA2845872A1
|
|
Herpes simplex virus nanoemulsion vaccine
|
|
WO2013006797A1
|
|
Human respiratory syncytial virus vaccine
|
|
CA2750233A1
|
|
Compositions for treatment and prevention of acne, methods of making the compositions, and methods of use thereof
|
|
US2009269394A1
|
|
Methods and compositions for treating onchomycosis
|
|
CA2722445A1
|
|
Nanoemulsions for treating fungal, yeast and mold infections
|
|
EP3023107A1
|
|
Nanoemulsion influenza vaccine
|
|
CA2721510A1
|
|
Methods for treating herpes virus infections
|
|
EP1951200A2
|
|
Nanoemulsion compositions having anti-inflammatory activity
|
|
WO2006110699A1
|
|
Quaternary ammonium halides for treatment of infectious conditions
|
|
US2005208083A1
|
|
Compositions for inactivating pathogenic microorganisms, methods of making the compositons, and methods of use thereof
|
|
EP1633322A2
|
|
Compositions for inactivating pathogenic microorganisms, methods of making the compositions, and methods of use thereof
|
